CRD-25

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCRD-25
Drug Alias NameBP reSync product (CRD Pharma/Cures Healthcare/Sana Pharmaceutical)combination for hypertension (CRD Pharmaceuticals)CRD-25
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsYes
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesCRD Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCRD Pharmaceuticals IncCures Health care SASana Pharma Industries
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A